NorthStrive Expands Patent Push Into Space Health With EL-22 and EL-32
PMGC Holdings' stock (ELAB) rose 4.43% to $6.37 after its subsidiary, NorthStrive, expanded its patent strategy into space health.
NorthStrive filed two U.S. patent applications covering EL-22 and EL-32 for muscle preservation during microgravity exposure.
The filings extend NorthStrive's existing work beyond obesity-related muscle loss into human spaceflight applications.